If You Invested $5,000 in Vertex Pharmaceuticals In 2016, This Is How Much You Would Have Today
Vertex Pharmaceuticals (NASDAQ: VRTX) is one of the largest biopharma businesses in the world, but you've probably never heard of anyone taking the medications that it makes. That's because it focuses on ones that treat rare diseases. Yet it has a market cap of $47 billion. I'm consistently surprised that it's possible to become so big and profitable by targeting conditions that affect few people worldwide.
But its stock hasn't always lived up to shareholders' hopes. In the past year, its shares have fallen by about 17%. Did the investors of yesteryear make a mistake or is this just a dent in an otherwise stellar run?
Image source: Getty Images.
Source Fool.com
